Riverine Ventures

Riverine Ventures is a venture capital firm based in Sausalito, California, founded in 2022. It focuses on partnering with emerging leaders in the healthcare and life sciences sectors to address complex challenges in these fields. By investing in innovative companies, Riverine Ventures aims to support the development of solutions that can improve health outcomes and advance scientific progress.

Scott Lancaster

Managing Partner

1 past transactions

Genomenon

Series B in 2022
Genomenon, Inc. is a software development company based in Ann Arbor, Michigan, that specializes in tools for genetic diagnosis and research. Founded in 2014, it provides a suite of diagnostic and discovery software that enables physicians, pharmaceutical companies, and researchers to quickly and accurately identify disease-causing variants from genomic-sequencing datasets. The flagship product, GENOMENON, automates the analysis of next-generation sequencing data, facilitating faster decision-making in cancer diagnosis and treatment, as well as in the study of inheritable diseases. By improving the efficiency of genomic interpretation, Genomenon aims to enhance patient outcomes and advance genetic research.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.